1. AHRO : Austin Health Research Online

Andrew M Scott

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Andrew M Scott
Full Name
Scott, Andrew M
 
Title
Prof
 
264-Scott.jpg picture
Department
 
Personal Site
https://www.onjcancercentre.org/
 
ORCID
Twitter
Biography
We love promoting your work, however you know best what to say. Please login and update your profile or let us know what you would like to say about yourself!
 
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Davis, Ian D
Subject:  Humans

Results 1-14 of 14 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
11-Feb-201418F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.Mertens, Laura S; Mir, M Carmen; Scott, Andrew M ; Lee, Sze Ting ; Fioole-Bruining, Annemarie; Vegt, Erik; Vogel, Wouter V; Manecksha, Rustom; Bolton, Damien M ; Davis, Ian D; Horenblas, Simon; van Rhijn, Bas W G; Lawrentschuk, Nathan
26-Nov-2013Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.Chang, Joe H; Lim Joon, Daryl ; Lee, Sze Ting ; Hiew, Chee-Yan; Esler, Stephen; Gong, Sylvia J; Wada, Morikatsu ; Clouston, David; O'Sullivan, Richard; Goh, Yin P; Tochon-Danguy, Henri; Chan, J Gordon ; Bolton, Damien M ; Scott, Andrew M ; Khoo, Vincent; Davis, Ian D
330-May-2012Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.Chang, Joe H; Lim Joon, Daryl ; Lee, Sze Ting ; Gong, Sylvia J; Anderson, Nigel J; Scott, Andrew M ; Davis, Ian D; Clouston, David; Bolton, Damien M ; Hamilton, Christopher S; Khoo, Vincent
47-Dec-2011Oncology health information quality on the Internet: a multilingual evaluation.Lawrentschuk, Nathan; Sasges, Deborah; Tasevski, Robert; Abouassaly, Robert; Scott, Andrew M ; Davis, Ian D
518-May-2011Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.Chang, Joe H; Joon, Daryl Lim; Lee, Sze Ting ; Gong, Sylvia J; Scott, Andrew M ; Davis, Ian D; Clouston, David; Bolton, Damien M ; Hamilton, Christopher S; Khoo, Vincent
612-Jun-2009Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.Lawrentschuk, Nathan; Lee, Fook-Thean; Jones, Gareth; Rigopoulos, Angela; Mountain, Angela; O'Keefe, Graeme J; Papenfuss, Anthony T; Bolton, Damien M ; Davis, Ian D; Scott, Andrew M 
71-Jan-2009Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.Kelly, Marcus P; Lee, Sze Ting ; Lee, Fook-Thean; Smyth, Fiona E; Davis, Ian D; Brechbiel, Martin W; Scott, Andrew M 
81-Jun-2007A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.Scott, Andrew M ; Tebbutt, Niall C ; Lee, Fook-Thean; Cavicchiolo, Tina; Liu, Zhanqi; Gill, Sanjeev; Poon, Aurora M T ; Hopkins, Wendie; Smyth, Fiona E; Murone, Carmel ; MacGregor, Duncan; Papenfuss, Anthony T; Chappell, Bridget; Saunder, Timothy H; Brechbiel, Martin W; Davis, Ian D; Murphy, Roger; Chong, Geoffrey ; Hoffman, Eric W; Old, Lloyd J
921-Jun-2006Xenografting tumour beneath the renal capsule using modern surgical equipment.Lawrentschuk, Nathan; Rigopoulos, Angela; Lee, Fook-Thean; Davis, Ian D; Scott, Andrew M ; Bolton, Damien M 
108-Jul-2005Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma.Harris, Marion T; Berlangieri, Salvatore U ; Cebon, Jonathan S ; Davis, Ian D; Scott, Andrew M 
1122-Feb-2005Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.Scott, Andrew M ; Liu, Zhanqi; Murone, Carmel ; Johns, Terrance G; MacGregor, Duncan; Smyth, Fiona E; Lee, Fook-Thean; Cebon, Jonathan S ; Davis, Ian D; Hopkins, Wendie; Mountain, Angela J; Rigopoulos, Angela; Hanai, Nobuo; Old, Lloyd J
122005Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.Murphy, R; Green, S; Ritter, G; Cohen, L; Ryan, D; Woods, W; Rubira, M; Cebon, Jonathan S ; Davis, Ian D; Sjolander, A; Kypridis, A; Kalnins, Renate M; McNamara, M; Moloney, M B; Ackland, J; Cartwright, Glenn A; Rood, J; Dumsday, G; Healey, K; Maher, D; Maraskovsky, Eugene; Chen, Y T; Hoffman, E W; Old, Lloyd J; Scott, Andrew M 
131-Oct-2001Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.Scott, Andrew M ; Lee, Fook-Thean; Hopkins, Wendie; Cebon, Jonathan S ; Wheatley, J M; Liu, Z; Smyth, Fiona E; Murone, Carmel ; Sturrock, S; MacGregor, Duncan; Hanai, N; Inoue, K; Yamasaki, M; Brechbiel, Martin W; Davis, Ian D; Murphy, R; Hannah, A; Lim-Joon, M; Chan, T; Chong, Geoffrey ; Ritter, G; Hoffman, E W; Burgess, Antony W; Old, Lloyd J
141-Sep-2001Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.Ramdave, S; Thomas, G W; Berlangieri, Salvatore U ; Bolton, Damien M ; Davis, Ian D; Danguy, H T; Macgregor, Duncan; Scott, Andrew M